Evergreen Biosciences®

Evergreen Biosciences is an early development stage company and pioneer in cryoprotectants for use in research and clinical grade cell tissue preservation. Our proprietary EVERLAST cryoprotectant is the first to target molecular stress pathways similar to drug targets and provides unique benefits to the preservation and storage of cells in the drug discovery, biobanking and regenerative medicine markets. Background - The Unmet Need: Cryopreservation technology has advanced little over the past 50 years. Methods of acquiring and preserving cells lack consistency and reliability. Traditional non-specific cryoprotectants such as DMSO are thought to target water transition to ice-crystal formation within and outside of cells. Cells preserved by traditional processes have reduced functionality and viability post-thaw due to significant toxicity. Read more about the need for reliable cryopreservation at: https://nam.edu/manufacturing-cell-therapies-the-paradigm-shift-in-health-care-of-this-century/ https://www.pctcelltherapy.com/cryopreservation-of-final-product Look out for more information coming soon...

Website

http://www.evergreenbiosciences.com

External link for Evergreen Biosciences®

Industry

Biotechnology Research

Company size

2-10 employees

Headquarters

New York, NY

Type

Privately Held

Founded

2018

Specialties

cryopreservation, cryoprotection, cell and gene therapy, consulting, and organ transplant